146 related articles for article (PubMed ID: 16260051)
1. Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension.
Affuso F; Palmieri EA; Di Conza P; Guardasole V; Fazio S
Int J Cardiol; 2006 Apr; 108(3):429-31. PubMed ID: 16260051
[TBL] [Abstract][Full Text] [Related]
2. Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension.
Pepke-Zaba J; Beardsworth A; Chan M; Angalakuditi M
Curr Med Res Opin; 2009 Oct; 25(10):2479-85. PubMed ID: 19686085
[TBL] [Abstract][Full Text] [Related]
3. Sustained benefit of tadalafil in patients with pulmonary arterial hypertension with prior response to sildenafil: a case series of 12 patients.
Tay EL; Geok-Mui MK; Poh-Hoon MC; Yip J
Int J Cardiol; 2008 Apr; 125(3):416-7. PubMed ID: 17407795
[No Abstract] [Full Text] [Related]
4. Oral tadalafil in pulmonary artery hypertension: a prospective study.
Aggarwal P; Patial RK; Negi PC; Marwaha R
Indian Heart J; 2007; 59(4):329-35. PubMed ID: 19126938
[TBL] [Abstract][Full Text] [Related]
5. Tadalafil improves oxygenation in a model of newborn pulmonary hypertension.
Tessler RB; Zadinello M; Fiori H; Colvero M; Belik J; Fiori RM
Pediatr Crit Care Med; 2008 May; 9(3):330-2. PubMed ID: 18446109
[TBL] [Abstract][Full Text] [Related]
6. Tadalafil therapy for pulmonary arterial hypertension.
Galiè N; Brundage BH; Ghofrani HA; Oudiz RJ; Simonneau G; Safdar Z; Shapiro S; White RJ; Chan M; Beardsworth A; Frumkin L; Barst RJ;
Circulation; 2009 Jun; 119(22):2894-903. PubMed ID: 19470885
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study.
Mukhopadhyay S; Sharma M; Ramakrishnan S; Yusuf J; Gupta MD; Bhamri N; Trehan V; Tyagi S
Circulation; 2006 Oct; 114(17):1807-10. PubMed ID: 17030688
[TBL] [Abstract][Full Text] [Related]
8. [Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension].
Sakuma M; Shirato K
Nihon Rinsho; 2008 Nov; 66(11):2157-61. PubMed ID: 19051736
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of PDE-5 inhibitor tadalafil in pulmonary arterial hypertension.
Bharani A; Patel A; Saraf J; Jain A; Mehrotra S; Lunia B
Indian Heart J; 2007; 59(4):323-8. PubMed ID: 19126937
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study.
Bendayan D; Shitrit D; Kramer MR
Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891
[TBL] [Abstract][Full Text] [Related]
11. Tadalafil (Adcirca) for pulmonary arterial hypertension.
Med Lett Drugs Ther; 2009 Nov; 51(1324):87-8. PubMed ID: 19890245
[No Abstract] [Full Text] [Related]
12. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.
Goudie AR; Lipworth BJ; Hopkinson PJ; Wei L; Struthers AD
Lancet Respir Med; 2014 Apr; 2(4):293-300. PubMed ID: 24717626
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema.
Fischler M; Maggiorini M; Dorschner L; Debrunner J; Bernheim A; Kiencke S; Mairbäurl H; Bloch KE; Naeije R; Brunner-La Rocca HP
Am J Respir Crit Care Med; 2009 Aug; 180(4):346-52. PubMed ID: 19520908
[TBL] [Abstract][Full Text] [Related]
14. Use of tadalafil for treating pulmonary arterial hypertension secondary to chronic obstructive pulmonary disease.
Kim HS; Park JH; Park SJ; Park JK; Lee HB
Korean J Intern Med; 2007 Mar; 22(1):37-9. PubMed ID: 17427645
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral tadalafil, a new long-acting phosphodiesterase-5 inhibitor, for the short-term treatment of pulmonary arterial hypertension in a dog.
Serres F; Nicolle AP; Tissier R; Gouni V; Pouchelon JL; Chetboul V
J Vet Med A Physiol Pathol Clin Med; 2006 Apr; 53(3):129-33. PubMed ID: 16533328
[TBL] [Abstract][Full Text] [Related]
16. Tadalafil as treatment for idiopathic pulmonary arterial hypertension.
de Carvalho AC; Hovnanian AL; Fernandes CJ; Lapa M; Jardim C; Souza R
Arq Bras Cardiol; 2006 Nov; 87(5):e195-7. PubMed ID: 17396193
[TBL] [Abstract][Full Text] [Related]
17. [Tadalafil: novel aspects of phosphodiesterase-5 inhibition in the treatment of pulmonary hypertension].
Gaudó Navarro J; Sueiro Bendito A
Arch Bronconeumol; 2011; 47 Suppl 7():26-31. PubMed ID: 23351473
[TBL] [Abstract][Full Text] [Related]
18. Should we pursue pulmonary vasodilation in patients with COPD?
Brusselle G
Lancet Respir Med; 2014 Apr; 2(4):252-4. PubMed ID: 24717617
[No Abstract] [Full Text] [Related]
19. Oral sildenafil therapy improves health-related quality of life and functional status in pulmonary arterial hypertension.
Wong RC; Koh GM; Choong PH; Yip WL
Int J Cardiol; 2007 Jul; 119(3):400-2. PubMed ID: 17064789
[TBL] [Abstract][Full Text] [Related]
20. Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension.
Nagaya N; Kyotani S; Uematsu M; Ueno K; Oya H; Nakanishi N; Shirai M; Mori H; Miyatake K; Kangawa K
Circulation; 2004 Jan; 109(3):351-6. PubMed ID: 14718403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
